Marijn Dekkers, CEO of the pharmaceutical giant Bayer, smiles during the annual balance news conference at the company's headquarters in Leverkusen, Germany, Monday, Feb. 28, 2011. Hefty special ... more 
Marijn Dekkers, CEO of the pharmaceutical giant Bayer, smiles during the annual balance news conference at the company's headquarters in Leverkusen, Germany, Monday, Feb. 28, 2011. Hefty special charges caused a fourth-quarter loss at Bayer AG, though the pharmaceutical and chemical company said Monday that revenues rose by 14.5 percent, led by increasing sales of high-tech materials and agricultural products. Bayer said it lost euro 145 million (US$ 199 million) in the quarter, compared with a net profit of euro 153 million a year earlier. It said one-time charges for the quarter totaled euro 954 million, more than double the previous year's figure, including impairment losses on the Schering brand name, which the company is dropping. less 
1 / 1
Associated Press | Photo By Frank Augstein
Wed, Mar 2, 2011 9:17 AM EST